An international private equity team at Goodwin Procter is advising on the sale of a German pharmaceutical holding company, including the full share acquisition of specialist German drug supplier Biotest AG.

Goodwin announced Sept. 17 that the firm is advising the Hong Kong-based Tiancheng International Investment Ltd. on the sale of its German subsidiary, Tiancheng Pharmaceutical Holding AG, to Spanish multinational pharmaceutical and chemical manufacturer Grifols SA.